Literature DB >> 7728057

Incidence of acute symptomatic toxoplasma retinochoroiditis in south London according to country of birth.

R E Gilbert1, M R Stanford, H Jackson, R E Holliman, M D Sanders.   

Abstract

OBJECTIVE: To determine the incidence of acute symptomatic toxoplasma retinochoroiditis presenting to ophthalmologists for patients born in Britain and elsewhere.
DESIGN: Population based, cross sectional study.
SETTING: 11 districts in south Greater London.
SUBJECTS: All patients presenting to NHS ophthalmologists with symptoms due to acute toxoplasma retinochoroiditis in 1992-3. MAIN OUTCOME MEASURE: Intraocular inflammation in association with a retinochoroidal scar, active adjoining retinitis, and IgG serum antibodies to toxoplasma.
RESULTS: The estimated incidence of acute symptomatic retinochoroiditis for all people born in Britain was 0.4/100,000/year. If a mean of two symptomatic episodes per lifetime is assumed, 100 people born in Britain may be affected each year, about a fifth of the estimated 500-600 congenitally infected people born each year.
CONCLUSIONS: A substantial proportion of people with acute symptomatic toxoplasma retinochoroiditis were born outside the country, and the number born in Britain was smaller than the number previously estimated to develop retinochoroidal lesions due to congenital toxoplasmosis. These findings suggest that prenatal screening for toxoplasmosis in Britain may be of limited benefit.

Entities:  

Mesh:

Year:  1995        PMID: 7728057      PMCID: PMC2549430          DOI: 10.1136/bmj.310.6986.1037

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  27 in total

Review 1.  Ocular toxoplasmosis.

Authors:  E S Perkins
Journal:  Br J Ophthalmol       Date:  1973-01       Impact factor: 4.638

2.  Congenital toxoplasmosis. A prospective study of 378 pregnancies.

Authors:  G Desmonts; J Couvreur
Journal:  N Engl J Med       Date:  1974-05-16       Impact factor: 91.245

3.  Variations in recurrent active toxoplasmic retinochoroiditis.

Authors:  C T Friedmann; D L Knox
Journal:  Arch Ophthalmol       Date:  1969-04

Review 4.  Ocular involvement in toxoplasmosis.

Authors:  A Rothova
Journal:  Br J Ophthalmol       Date:  1993-06       Impact factor: 4.638

5.  Ocular toxoplasmosis among Negro immigrants in London.

Authors:  J R Chesterton; E S Perkins
Journal:  Br J Ophthalmol       Date:  1967-09       Impact factor: 4.638

6.  Modelling toxoplasma incidence from longitudinal seroprevalence in Stockholm, Sweden.

Authors:  D J Nokes; M Forsgren; E Gille; I Ljungström
Journal:  Parasitology       Date:  1993-07       Impact factor: 3.234

7.  Modeling age- and time-specific incidence from seroprevalence:toxoplasmosis.

Authors:  A E Ades; D J Nokes
Journal:  Am J Epidemiol       Date:  1993-05-01       Impact factor: 4.897

8.  Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group.

Authors:  N G Guerina; H W Hsu; H C Meissner; J H Maguire; R Lynfield; B Stechenberg; I Abroms; M S Pasternack; R Hoff; R B Eaton
Journal:  N Engl J Med       Date:  1994-06-30       Impact factor: 91.245

9.  Termination of pregnancy for maternal toxoplasmosis.

Authors:  A Berrebi; W E Kobuch; M H Bessieres; M C Bloom; M Rolland; M F Sarramon; C Roques; A Fournié
Journal:  Lancet       Date:  1994-07-02       Impact factor: 79.321

10.  An outbreak of toxoplasmosis linked to cats.

Authors:  S Stagno; A C Dykes; C S Amos; R A Head; D D Juranek; K Walls
Journal:  Pediatrics       Date:  1980-04       Impact factor: 7.124

View more
  9 in total

1.  Human antiretinal antibodies in toxoplasma retinochoroiditis.

Authors:  R M Whittle; G R Wallace; R A Whiston; D C Dumonde; M R Stanford
Journal:  Br J Ophthalmol       Date:  1998-09       Impact factor: 4.638

2.  Incidence of toxoplasma retinochoroiditis.

Authors:  D O Ho-Yen; A W Joss; L Dargie
Journal:  BMJ       Date:  1995-09-09

3.  Clinical manifestation and prognosis of active ocular toxoplasmosis in Iran.

Authors:  Farzan Kianersi; Afsaneh Naderi Beni; Zahra Naderi Beni
Journal:  Int Ophthalmol       Date:  2012-06-26       Impact factor: 2.031

4.  Toxoplasma and the eye.

Authors:  J Hay; G N Dutton
Journal:  BMJ       Date:  1995-04-22

Review 5.  Epidemiology of and diagnostic strategies for toxoplasmosis.

Authors:  Florence Robert-Gangneux; Marie-Laure Dardé
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

6.  Fuchs' heterochromic cyclitis: a post-infectious manifestation of ocular toxoplasmosis?

Authors:  Akesbi Jad; Terrada Céline; Bodaghi Bahram; LeHoang Phuc; Cassoux Nathalie
Journal:  Int Ophthalmol       Date:  2012-10-16       Impact factor: 2.031

7.  Systemic T cell response to Toxoplasma gondii antigen in patients with ocular toxoplasmosis.

Authors:  Fatih Fatoohi; Grégoire Jacques Noël Cozon; Martine Wallon; Laurent Kodjikian; François Peyron
Journal:  Jpn J Ophthalmol       Date:  2006 Mar-Apr       Impact factor: 2.211

Review 8.  Toxoplasmosis and epilepsy--systematic review and meta analysis.

Authors:  Edgard B Ngoungou; Devender Bhalla; Amandine Nzoghe; Marie-Laure Dardé; Pierre-Marie Preux
Journal:  PLoS Negl Trop Dis       Date:  2015-02-19

Review 9.  Ocular toxoplasmosis: a review of the current diagnostic and therapeutic approaches.

Authors:  Dimitrios Kalogeropoulos; Hercules Sakkas; Bashar Mohammed; Georgios Vartholomatos; Konstantinos Malamos; Sreekanth Sreekantam; Panagiotis Kanavaros; Chris Kalogeropoulos
Journal:  Int Ophthalmol       Date:  2021-08-09       Impact factor: 2.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.